Re:Wegovy and Ozempic (semaglutide) associated with reductio...
by JumpCrisscross on Monday June 03, 2024 @02:57PM
(#40566135)
> these drugs are not under patent
"Semaglutide is expected to become patent-free in the United States no earlier than December 2031" [1].
We could probably strike a volume deal for ~$200 for 5 years and then $75 (the upper end of your study’s estimate for manufacturing cost) for another 5.
Re:Wegovy and Ozempic (semaglutide) associated with reductio...
by hnburnsy on Monday June 03, 2024 @03:30PM
(#40566565)
https://www.cnbc.com/2024/04/30/ftc-challenges-patents-held-...
My understanding is that they are patentening the drug+device and or the dosing, not the molecule. Looks like the FTC is clamping down on it.
https://www.healthline.com/health-news/how-affordable-could-...